Our segmented scRNA-seq data originating from ER+, HER2+, and TN BC further supported that higher proportions were seen in cell populations that express positive-related genes compared to negative-related genes against EMT or invasion (Figure 4B,D). The gene discussed is ERBB2; the disease is breast cancer.